jimnyc
10-02-2021, 11:31 AM
If I had to make a choice today, my choice is still to take the vaccine. Say as you will, my choice. The stats show nearing 5 million deaths, and a very very highly successful rate of success for the vaccine thus far.
But that's not to say that other medications can't be used as an alternative. That they aren't effective. And many folks prefer this route and should be afforded that - not taken away or lied about.
---
Merck & Co. Cheers Experimental Antiviral Pill for COVID-19 That Cuts Death and Hospitalization By Half – Sort of Like HCQ and Ivermectin
Merck & Co. already failed twice in its quest to develop a vaccine, but now says an experimental antiviral pill for COVID-19 reduces the risk of hospitalization and even death by half of the people infected with the virus when given early.
During clinical trial, Molnupiravir, was given to the patients recently infected with COVID-19 twice a day and the results were outstanding according to the company.
Within the next two weeks, Merck will ask health officials for emergency use authorization for the drug in the US and around the world.
The liberal media is touting the news but downplayed and lied about hydroxychloroquine (HCQ) and Ivermectin for over a year now. This is despite HCQ’s 75% success rate in early treatment mortality tests and Ivermectin’s solid results in India and elsewhere.
It’s almost like the government, Dr. Fauci and the American medical community were lying to the public all along?
Weird, huh?
So when will we see these killers sent to prison?
More from CBS News: (https://www.cbsnews.com/news/covid-19-pill-merck-cut-deaths-hospitalizations/)
Merck and its partner, Ridgeback Biotherapeutics, said early results showed patients who received the drug, called molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalization and deaths as patients who received a dummy pill. The study tracked 775 adults with mild-to-moderate COVID-19 who were considered at higher risk for severe disease due to health problems such as obesity, diabetes or heart disease.
Among patients taking molnupiravir, 7.3% were either hospitalized or died at the end of 30 days, compared with 14.1% of those getting the dummy pill. There were no deaths in the drug group after that time period compared with eight deaths in the placebo group, according to Merck.The results were released by the company and have not been peer reviewed. Merck said it plans to present them at a future medical meeting.
“It exceeded what I thought the drug might be able to do in this clinical trial,” said Dr. Dean Li, vice president of Merck research. “When you see a 50% reduction in hospitalization or death that’s a substantial clinical impact.”
Side effects were reported by both groups in the Merck trial, but they were slightly more common among the group that received a dummy pill. The company did not specify the problems.
Earlier study results showed the drug did not benefit patients who were already hospitalized with severe disease.
Rest - https://www.thegatewaypundit.com/2021/10/merck-co-cheers-experimental-antiviral-pill-covid-19-cuts-death-hospitalization-half-sort-like-hcq-ivermectin/
But that's not to say that other medications can't be used as an alternative. That they aren't effective. And many folks prefer this route and should be afforded that - not taken away or lied about.
---
Merck & Co. Cheers Experimental Antiviral Pill for COVID-19 That Cuts Death and Hospitalization By Half – Sort of Like HCQ and Ivermectin
Merck & Co. already failed twice in its quest to develop a vaccine, but now says an experimental antiviral pill for COVID-19 reduces the risk of hospitalization and even death by half of the people infected with the virus when given early.
During clinical trial, Molnupiravir, was given to the patients recently infected with COVID-19 twice a day and the results were outstanding according to the company.
Within the next two weeks, Merck will ask health officials for emergency use authorization for the drug in the US and around the world.
The liberal media is touting the news but downplayed and lied about hydroxychloroquine (HCQ) and Ivermectin for over a year now. This is despite HCQ’s 75% success rate in early treatment mortality tests and Ivermectin’s solid results in India and elsewhere.
It’s almost like the government, Dr. Fauci and the American medical community were lying to the public all along?
Weird, huh?
So when will we see these killers sent to prison?
More from CBS News: (https://www.cbsnews.com/news/covid-19-pill-merck-cut-deaths-hospitalizations/)
Merck and its partner, Ridgeback Biotherapeutics, said early results showed patients who received the drug, called molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalization and deaths as patients who received a dummy pill. The study tracked 775 adults with mild-to-moderate COVID-19 who were considered at higher risk for severe disease due to health problems such as obesity, diabetes or heart disease.
Among patients taking molnupiravir, 7.3% were either hospitalized or died at the end of 30 days, compared with 14.1% of those getting the dummy pill. There were no deaths in the drug group after that time period compared with eight deaths in the placebo group, according to Merck.The results were released by the company and have not been peer reviewed. Merck said it plans to present them at a future medical meeting.
“It exceeded what I thought the drug might be able to do in this clinical trial,” said Dr. Dean Li, vice president of Merck research. “When you see a 50% reduction in hospitalization or death that’s a substantial clinical impact.”
Side effects were reported by both groups in the Merck trial, but they were slightly more common among the group that received a dummy pill. The company did not specify the problems.
Earlier study results showed the drug did not benefit patients who were already hospitalized with severe disease.
Rest - https://www.thegatewaypundit.com/2021/10/merck-co-cheers-experimental-antiviral-pill-covid-19-cuts-death-hospitalization-half-sort-like-hcq-ivermectin/